Synergistic potential of CDH3 in targeting CRC metastasis and enhancing immunotherapy
Abstract Background Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, particularly due to advanced-stage metastasis. P-cadherin (CDH3), a potential therapeutic target, is highly expressed in CRC tissues and associated with poor prognosis and metastasis. However, the mechan...
Saved in:
| Main Authors: | Chen Fu, Jia Fu, Chaoyue Liu, Zhaojin Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-13845-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CDH3 promotes the progression of lung adenocarcinoma through driving epithelial-mesenchymal transition progress
by: Wenlin Gong, et al.
Published: (2025-08-01) -
A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor-specificity
by: Alyssa Synan, et al.
Published: (2025-12-01) -
A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer
by: Peter Jung, et al.
Published: (2024-12-01) -
Using Mask Technique and Center Detection for Congenital Dislocation of the Hip (CDH) Diagnosis
by: Nidal AL-Assady, et al.
Published: (2007-07-01) -
Calcium-dependent adhesion protein CDH18, a potential biomarker for prognosis in uterine corpus endometrial carcinoma
by: Xiaoxuan Tang, et al.
Published: (2025-02-01)